I am amazed at how the price is just pegged so firmly where it is. Five months in the 0.10-0.14 range with the occasional temporary pull up or down. That translates to a company valued at $20-30M.

How does it stay glued here despite massive plans to expand trials and partnerships to Europe while at the same time our cash on hand approaches 0. I still think we'll see some volatility next week but who actually values the company at this level. Either it's much less or much more.